Profound Medical Corp.
PRN.TO
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -26.00% | -48.27% | -14.82% | 0.84% | -7.60% |
| Total Depreciation and Amortization | -15.00% | -14.42% | -8.15% | 4.00% | 73.72% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 40.80% | 1.88% | -26.30% | -34.25% | -52.86% |
| Change in Net Operating Assets | -198.64% | 148.61% | -11.82% | 94.92% | 615.23% |
| Cash from Operations | -49.71% | -53.89% | -26.53% | -2.42% | -13.42% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 59.79% | 13.33% | -59.95% | -179.14% | -168.88% |
| Issuance of Common Stock | 70.91% | 70.90% | 69.15% | 2,228.62% | 760.90% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -63.31% | -63.31% | -63.31% | -- | -1,147.65% |
| Cash from Financing | 85.52% | 78.63% | 70.26% | 2,900.77% | 110.93% |
| Foreign Exchange rate Adjustments | 42.97% | 137.40% | -249.19% | -662.66% | -296.73% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 64.67% | 121.48% | 391.19% | 241.35% | 48.33% |